Correlation Between OptiCept Technologies and AlzeCure Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OptiCept Technologies and AlzeCure Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OptiCept Technologies and AlzeCure Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OptiCept Technologies AB and AlzeCure Pharma, you can compare the effects of market volatilities on OptiCept Technologies and AlzeCure Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OptiCept Technologies with a short position of AlzeCure Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of OptiCept Technologies and AlzeCure Pharma.

Diversification Opportunities for OptiCept Technologies and AlzeCure Pharma

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between OptiCept and AlzeCure is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding OptiCept Technologies AB and AlzeCure Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AlzeCure Pharma and OptiCept Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OptiCept Technologies AB are associated (or correlated) with AlzeCure Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AlzeCure Pharma has no effect on the direction of OptiCept Technologies i.e., OptiCept Technologies and AlzeCure Pharma go up and down completely randomly.

Pair Corralation between OptiCept Technologies and AlzeCure Pharma

Assuming the 90 days trading horizon OptiCept Technologies AB is expected to generate 1.26 times more return on investment than AlzeCure Pharma. However, OptiCept Technologies is 1.26 times more volatile than AlzeCure Pharma. It trades about 0.06 of its potential returns per unit of risk. AlzeCure Pharma is currently generating about -0.06 per unit of risk. If you would invest  310.00  in OptiCept Technologies AB on September 14, 2024 and sell it today you would earn a total of  190.00  from holding OptiCept Technologies AB or generate 61.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

OptiCept Technologies AB  vs.  AlzeCure Pharma

 Performance 
       Timeline  
OptiCept Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OptiCept Technologies AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
AlzeCure Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AlzeCure Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

OptiCept Technologies and AlzeCure Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OptiCept Technologies and AlzeCure Pharma

The main advantage of trading using opposite OptiCept Technologies and AlzeCure Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OptiCept Technologies position performs unexpectedly, AlzeCure Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzeCure Pharma will offset losses from the drop in AlzeCure Pharma's long position.
The idea behind OptiCept Technologies AB and AlzeCure Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments